The Technology Centre of New Jersey
675 U.S. Route One, South
About Advaxis, Inc.Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies that enlist the body’s own immune system to fight cancer.
CEO: Daniel O’Connor
CFO: Sara Bonstein
CSO (Scientific): Robert Petit
Please click here for Advaxis job opportunities.
Please click here for clinical trial information.
Tweets by Advaxis
460 articles with Advaxis, Inc.
Recent HPV Findings by Centers for Disease Control and Prevention (CDC) and Prevention Validate Advaxis, Inc.'s Treatable Population
Advaxis, Inc. Partners With Gynecologic Oncology Group For Phase II Study of Company's Lead Cervical Cancer Vaccine
Advaxis, Inc. Appoints Thomas A. Moore To Its Board Of Directors; Todd Derbin Resigns As Chairman Of The Board
Advaxis, Inc. Begins Patient Education Initiative To Promote Better Understanding Of Cervical Cancer Vaccines
Advaxis, Inc. Announces Approvals Of Israeli And Mexican Regulators To Commence Clinical Study Of Its Listeria Cancer Vaccine Candidate For Cervical Cancer
Advaxis, Inc. To Present At The 5th Annual North American Forum For Investing And Partnering In Biotech And Medtech In Boston
Advaxis, Inc.'s Listeria Cancer Vaccine Receives Regulatory Approval For Phase I/II Testing In Cervical Cancer